Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

The risk of developing dementia in the United States is much higher than previously estimated, according to a new study ...

A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

"Our study results forecast a dramatic rise in the burden from dementia in the United States over the coming decades, with ...

Levels were found to drop gradually, from women with no signs of memory ... Supports New Blood-Based Biomarker to Detect Early Brain Changes Leading to Cognitive Impairment and Dementia Dec.

China has rolled out a national action plan to address senile dementia, which poses significant challenges to the well-being ...